Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biocircuits to ship IOS point-of-care immunodiagnostic system in early 1996.

This article was originally published in The Gray Sheet

Executive Summary

BIOCIRCUITS' IOS POINT-OF-CARE IMMUNODIAGNOSTIC SYSTEM SHIPMENTS are expected to begin in early 1996, the company says. Cleared for marketing by FDA on Dec. 1, the physician-office/point-of-care instrument is being sold for $6,000. The intended market for the device is the approximately 45,000 small- to medium-sized physician practices that already do clinical chemistry and/or hematology testing in-house but use outside labs for immunodiagnostic testing.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT005155

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel